Sectors
BSX
Boston Scientific Corporation
50.44
1 x 50.30
1 x 50.37
bid
ask
-
0.01
0.01%
09:39 AM
timesize
| Ytd | -47.10% | |
| 1y | -50.91% |
50.14
day range
50.70
42.63
52 week range
108.14
| Open | 50.70 | Prev Close | 50.45 | Low | 50.14 | High | 50.70 | Mkt Cap | 74.91B |
| Vol | 451.43K | Avg Vol | 20.89M | EPS | 3.10 | P/E | 16.26 | Forward P/E | 14.34 |
| Beta | 0.56 | Short Ratio | 1.42 | Inst. Own | 96.11% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 45.92 | 200-d Avg | 71.69 | 1yr Est | 62.69 |
| Income Statement | |||
| Total Revenue | 5.44B | ||
| Revenues (USD) | 5.44B | ||
| Cost of Revenue | 1.59B | ||
| Gross Profit | 3.85B | ||
| Operating Expenses | 2.67B | ||
| Research and Development Expense | 554.00M | ||
| Selling, General and Administrative Expense | 1.80B | ||
| Operating Income | 1.18B | ||
| Interest Expense | 96.00M | ||
| Income Tax Expense | 155.00M | ||
| Net Income | 907.00M | ||
| Net Income Common Stock | 907.00M | ||
| Net Income Common Stock (USD) | 907.00M | ||
| Consolidated Income | 905.00M | ||
| Net Income to Non-Controlling Interests | -2.00M | ||
| Earnings per Basic Share | 0.62 | ||
| Earnings per Basic Share (USD) | 0.62 | ||
| Earnings per Diluted Share | 0.61 | ||
| Earning Before Interest & Taxes (EBIT) | 1.16B | ||
| Earning Before Interest & Taxes (USD) | 1.16B | ||
| Weighted Average Shares | 1.47B | ||
| Weighted Average Shares Diluted | 1.47B | ||
| Balance Sheet | |||
| Cash and Equivalents | 539.00M | ||
| Cash and Equivalents (USD) | 539.00M | ||
| Investments | 2.25B | ||
| Investments Non-Current | 2.25B | ||
| Trade and Non-Trade Receivables | 3.05B | ||
| Current Assets | 7.97B | ||
| Property, Plant & Equipment Net | 4.13B | ||
| Total Assets | 45.22B | ||
| Debt Current | 1.71B | ||
| Total Debt | 12.62B | ||
| Current Liabilities | 6.43B | ||
| Debt Non-Current | 10.92B | ||
| Total Liabilities | 20.04B | ||
| Accumulated Retained Earnings (Deficit) | 7.82B | ||
| Accumulated Other Comprehensive Income | -304.00M | ||
| Shareholders Equity | 24.93B | ||
| Shareholders Equity (USD) | 24.93B | ||
| Assets Non-Current | 37.24B | ||
| Total Debt (USD) | 12.62B | ||
| Goodwill and Intangible Assets | 25.56B | ||
| Inventory | 3.24B | ||
| Liabilities Non-Current | 13.62B | ||
| Trade and Non-Trade Payables | 1.23B | ||
| Tax Assets | 4.30B | ||
| Tax Liabilities | 221.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 355.00M | ||
| Net Cash Flow from Financing | -410.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -890.00M | ||
| Capital Expenditure | -195.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -256.00M | ||
| Issuance (Purchase) of Equity Shares | -2.00B | ||
| Issuance (Repayment) of Debt Securities | 1.66B | ||
| Net Cash Flow from Investing | -1.96B | ||
| Net Cash Flow from Operations | 1.47B | ||
| Effect of Exchange Rate Changes on Cash | 1000.00K | ||
| Share Based Compensation | 87.00M | ||